CLEC5A

From WikiMD's Wellness Encyclopedia

CLEC5A[edit | edit source]

CLEC5A, also known as C-type lectin domain family 5 member A, is a protein encoded by the CLEC5A gene in humans. This protein is a member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily, which is characterized by its ability to bind carbohydrates in a calcium-dependent manner. CLEC5A is primarily expressed on the surface of myeloid cells, such as macrophages and dendritic cells, and plays a significant role in the immune response.

Structure[edit | edit source]

CLEC5A is a type II transmembrane protein, meaning it has a single transmembrane domain with the N-terminus located inside the cell and the C-terminus outside. The extracellular portion contains a C-type lectin-like domain, which is responsible for its carbohydrate-binding properties. This domain is crucial for the protein's role in pathogen recognition and immune signaling.

Function[edit | edit source]

CLEC5A is involved in the innate immune response, particularly in the recognition of pathogens. It acts as a pattern recognition receptor (PRR) that can bind to certain viral and bacterial components. One of its well-studied roles is in the recognition of dengue virus, where CLEC5A binding leads to the activation of pro-inflammatory cytokine production, contributing to the pathogenesis of dengue fever.

In addition to its role in viral infections, CLEC5A has been implicated in the regulation of inflammatory responses. It can modulate the activity of other immune cells and influence the production of cytokines, which are critical for orchestrating the immune response.

Clinical Significance[edit | edit source]

Due to its involvement in inflammatory processes, CLEC5A is a potential target for therapeutic intervention in diseases characterized by excessive inflammation, such as autoimmune diseases and certain viral infections. Inhibitors of CLEC5A are being explored as potential treatments to reduce inflammation and tissue damage in these conditions.

Research[edit | edit source]

Ongoing research is focused on understanding the precise mechanisms by which CLEC5A contributes to immune responses and its potential as a therapeutic target. Studies are also exploring its role in other diseases, such as cancer, where the immune system plays a critical role in disease progression and treatment.

Also see[edit | edit source]



WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD